Stay updated with breaking news from Retinal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The factors that are driving the Retinal Vein Occlusion Market are Rise in a patient suffering from lymphoma, Glaucoma, Myeloma, a Growing rate of atherosclerosis and diabetes, a rise in prevalence
Research sheds light on severity for gene variants; establishes outcome measures for therapeutic trials.
A quick and pain-free scan of the human eyeball could one day help doctors identify 'fast agers', who are at greater risk of early mortality.
SYDNEY, Jan. 19 (Xinhua) -- The difference between the apparent age of somebody eyes and that person actual age can shed light on their current or future health
- The retinal vein occlusion market is estimated to exceed valuation of US$ 32.5 Bn by 2031 - Rising adoption of modern treatment options such as photocoagulation and intravitreal injections